PT3724336T - Improved compound for treatment of heart failure - Google Patents
Improved compound for treatment of heart failureInfo
- Publication number
- PT3724336T PT3724336T PT188338495T PT18833849T PT3724336T PT 3724336 T PT3724336 T PT 3724336T PT 188338495 T PT188338495 T PT 188338495T PT 18833849 T PT18833849 T PT 18833849T PT 3724336 T PT3724336 T PT 3724336T
- Authority
- PT
- Portugal
- Prior art keywords
- treatment
- heart failure
- improved compound
- compound
- improved
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/113—Antisense targeting other non-coding nucleic acids, e.g. antagomirs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/323—Chemical structure of the sugar modified ring structure
- C12N2310/3231—Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17207738 | 2017-12-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3724336T true PT3724336T (en) | 2022-04-06 |
Family
ID=60673706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT188338495T PT3724336T (en) | 2017-12-15 | 2018-12-14 | Improved compound for treatment of heart failure |
Country Status (1)
| Country | Link |
|---|---|
| PT (1) | PT3724336T (en) |
-
2018
- 2018-12-14 PT PT188338495T patent/PT3724336T/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202006746B (en) | Methods of treatment | |
| EP3261713A4 (en) | Blood pump for treatment of bradycardia | |
| IL270752B (en) | Pyrrolopyridine-aniline compounds for treatment of dermal disorders | |
| GB201804514D0 (en) | Treatment of pyroptosis | |
| EP3169259A4 (en) | Cardiac cryolipolysis for the treatment of cardiac arrhythmia | |
| IL257355B (en) | Selection of patients for combination therapy | |
| IL259297A (en) | Heterocyclic compounds for the treatment of disease | |
| GB2564801B (en) | Implantable scaffolds for treatment of sinusitis | |
| SG11201704781XA (en) | Prevention of progressive heart failure | |
| IL250662A0 (en) | Tissue protecting devices for treatment of congestive heart failure and other conditions | |
| IL280243A (en) | 17beta-heterocyclyl-digitalis like compounds for the treatment of heart failure | |
| EP3256137A4 (en) | Method of treating heart failure | |
| GB201804515D0 (en) | Treatment of necroptosis | |
| IL275273A (en) | Improved compound for treatment of heart failure | |
| EP3259346A4 (en) | P63 inactivation for the treatment of heart failure | |
| GB201907305D0 (en) | Treatment of conditions | |
| SG11202005850VA (en) | Methods of treatment of hypertrigl yceridemia | |
| ES3049333T3 (en) | Compounds for the treatment of respiratory diseases | |
| EP3503965B8 (en) | Treatment of cardiac dysfunction | |
| SG11201705889VA (en) | Prevention or Treatment of Uratic or Gouty Diseases | |
| EP3601565A4 (en) | Mir-92 inhibitors for treatment of heart failure | |
| GB201514302D0 (en) | Lactobacilli for treating cardiac dysfunction | |
| PT3724336T (en) | Improved compound for treatment of heart failure | |
| PL3710043T3 (en) | Fgf10 for the treatment of heart diseases | |
| HK40070316B (en) | Heterocyclic compounds for the treatment of disease |